GSK inks deal to co-promote Auxilium testosterone gel

Amid a surge in sales of testosterone products, GlaxoSmithKline ($GSK) has signed on to market a testosterone-replacement gel from Auxilium Pharmaceuticals. GSK gets exclusive co-promotion rights in the U.S. through 2015; it's expected to start detailing to doctors early next quarter. Report